1. Oda D, Rivera V, Ghanee N, Kenny E, Dawson K. Odontogenic keratocyst: The northwestern USA experience. J Contemp Dent Pract. 2000 Feb; 1(2): 60-74. 2. Reichart PA, Philipsen HP, Sciubba JJ. The new classification of head and neck tumours (WHO)-any changes? Oral Oncol. 2006 Sept;42(8):757-8. 3. Soluk Tekkeşın M, Mutlu S, Olgaç V.
Expressions of bax, bcl-2 and Ki-67 in
odontogenic keratocysts (keratocystic odonto-genic tumor) in comparison with ameloblasto-mas and radicular cysts. Turk Patoloji Derg. 2012;28(1):49-55. 4. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & Maxillofacial Pathology. 3rded.
Philadelphia: Saunders; 2009. Chapter:15. 5. Regezzi JA, Sciubba JJ, Jordan RCK: Oral
Pathology: Clinical Pathologic Correlations. 5th ed. Philadelphia, Elsevier Saunders; 2008, 245. 6. Rangiani A, Motahhary P. Evaluation of bax and bcl-2 expression in odontogenic keratocysts and orthokeratinized odontogenic cysts: A comparison of two cysts. Oral Oncol. 2009 Jul;45(7):e41-e44. 7. Billen LP, Kokoski CL, Lovell JF, Leber B,
Andrews DW. Bcl-XL inhibits membrane
permeabilization by competing with Bax. PLoS Biol. 2008 Jun;6(6):e147. 8. Baliga BC, Kumar S. Role of bcl-2 family of proteins in malignancy. Hematol Oncol. 2002 Jun; 20(2):63-74. 9. Krajewski S, Hugger A, Krajewska M, Reed JC, Mai JK. Development expression patterns of bcl-2, bcl-X, bax and bak inteeth. Cell Death Differ. 1998 May; 5(5):408-415. 10. Shear M. The aggressive nature of the
odontogenic keratocyst: is it a benign cystic
neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol. 2002 Jun; 38(4):323-331. 11. Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, et al. Prognostic significance of Bcl2 and Bax protein expression in the patients with oral
squamous cell carcinoma. J Oral Pathol Med. 2009 Mar; 38(3):307-13. 12. Kumar V, Abbas AK, Aster JC. Robbins basic
pathology: Elsevier Health Sciences; 2012. 13. Jahanshahi Gh, Talebi A, Shirvani A.
Expression of Bcl-2 in the epithelial lining of odontogenic keratocysts. J of Dent Tehran Univ of Med Sci. 2006 Nov; 3(1):30-35. 14. Saghravanian N, Habibi A, Mohtasham N,
Afzal Aghaie M, Shiva A, Babazadeh S.
Evaluation of MDM2 and P53 expression in
dentigerous, radicular and residual cysts by
immunuhistochemistry. J of Mashhad Dent Sch. 2009 May;33(2):145-52. 15. Piatelli A, Fomni M, Rubini C. Differentiation of odontogenic keratocyst from other odonto-genic cysts by the expression of BCL 2
immunoreactivity. Oral Oncol. 1998 Sept; 34(5): 404-407. 16. Narain P, Parihar S, Verma A, Sharma A.
Differentiation of ameloblastoma, odontogenic
keratocyst and dentigerous cysts by BCL-2
Protein-an immunohistochemical study. Indian J of Contemp Dent. 2015 Jul; 3(2):54-9. 17. Razavi SM, Torabinia N, Mohajeri MR,
Shahriyary S, Ghalegolab S, Nouri S. Expres-sion of Bcl-2 and epithelial growth factor recep-tor
proteins in keratocystic odontogenic tumor in comparison with dentigerous cyst and
ameloblastoma. Dent Res J (Isfahan). 2015 Jul-Aug; 12(4):342-7. 18. Kolář Z, Geierová M, Bouchal J, Pazdera J, Zbořil V, Tvrdý P. Immunohistochemical
analysis of the biological potential of
odontogenic keratocysts. J Oral Pathol Med. 2006 Feb;35(2):75-80.
|